ESR1 and breast carcinoma: To demonstrate the model’s ability to predict prognosis in clinical situations, the optimized model was trained in a training dataset and then applied to an independent test dataset, the Ur-Rehman dataset, which contains curated data from 856 ER+ breast cancer patients [52].